A Charming Chat: Part Two with CMO of UnitedHealthCare on covid 19 treatment
Channel: The Doctor Weighs In
Date: 08/06/2020

One area of Covid 19 treatment that has been successful in the past, but not leveraged as much is adoptive immunity of transferring sensitized serum to patients who are just starting to develop symptoms with the serum of patients who have overcome the disease. 

In this interview, we talk with Chief Medical Officer (CMO) of UnitedHealth Group, Dr. Migliori to discuss their collaboration with the Mayo Clinic for a clinical trial that has recruited over 27,000 patients. 

This enormous collaboration with UnitedHealthcare involves over 7,000 doctors, 2400 participating centers including John Hopkins, Mt. Sinai and several others including local community hospitals. 

UHG helped administer program with both financial support and patient recruitment. The health insurance giant serves over 140 million and has used their extensive network to bring this clinical trial to a pace in which people are moving is unprecendented and very encouraging. 

This is Part Two of a three part series.

You can also check out the article on thedoctorweighsin.com. To enroll now, visit: https://www.uscovidplasma.org/

Help stop the spread of the coronavirus.